
    
      The first phase assesses single ascending doses of EDP-297 or placebo in healthy subjects. A
      "fasted" and "fed" two-part cohort will also assess food effect.

      The second phase assesses multiple ascending doses of EDP-297 or placebo for 14-days in
      healthy subjects.

      Each cohort within each phase will enroll a total of 8 subjects who will be randomized to
      receive EDP-297 or placebo. The cohort assessing food effect will enroll 10 subjects
      randomized to receive EDP-297 or placebo
    
  